| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukemia, Myeloid, Acute | 16 | 2025 | 571 | 3.020 |
Why?
|
| STAT3 Transcription Factor | 8 | 2021 | 230 | 1.840 |
Why?
|
| STAT5 Transcription Factor | 3 | 2021 | 89 | 1.130 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 4 | 2021 | 96 | 0.930 |
Why?
|
| Apoptosis | 8 | 2020 | 1928 | 0.760 |
Why?
|
| Antineoplastic Agents | 7 | 2023 | 1849 | 0.700 |
Why?
|
| Interleukin-10 | 1 | 2022 | 188 | 0.700 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 323 | 0.620 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 3 | 2024 | 75 | 0.590 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 501 | 0.570 |
Why?
|
| Gene Rearrangement | 3 | 2016 | 330 | 0.510 |
Why?
|
| Transcriptome | 3 | 2021 | 1135 | 0.480 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2015 | 6 | 0.470 |
Why?
|
| Mitoxantrone | 1 | 2015 | 27 | 0.470 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2021 | 829 | 0.450 |
Why?
|
| Enzyme Inhibitors | 2 | 2016 | 606 | 0.450 |
Why?
|
| Methyltransferases | 2 | 2016 | 83 | 0.440 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2015 | 234 | 0.430 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 592 | 0.380 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2023 | 103 | 0.350 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 712 | 0.340 |
Why?
|
| Recurrence | 3 | 2025 | 1469 | 0.320 |
Why?
|
| Signal Transduction | 4 | 2019 | 4917 | 0.300 |
Why?
|
| Cell Line, Tumor | 8 | 2021 | 3794 | 0.300 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2022 | 684 | 0.300 |
Why?
|
| Receptors, Opioid, kappa | 6 | 2000 | 23 | 0.290 |
Why?
|
| Child, Preschool | 13 | 2025 | 14861 | 0.280 |
Why?
|
| Naphthalenes | 2 | 2020 | 37 | 0.280 |
Why?
|
| Myelopoiesis | 1 | 2007 | 13 | 0.280 |
Why?
|
| Child | 17 | 2025 | 25846 | 0.270 |
Why?
|
| Immunophenotyping | 2 | 2025 | 345 | 0.260 |
Why?
|
| Histone-Lysine N-Methyltransferase | 3 | 2024 | 176 | 0.260 |
Why?
|
| Myeloid Cells | 1 | 2007 | 121 | 0.260 |
Why?
|
| Infant | 10 | 2024 | 13232 | 0.250 |
Why?
|
| Interleukin-6 | 2 | 2022 | 439 | 0.250 |
Why?
|
| Adolescent | 14 | 2025 | 20549 | 0.250 |
Why?
|
| Immunotherapy | 2 | 2025 | 750 | 0.250 |
Why?
|
| Sulfonamides | 2 | 2020 | 289 | 0.240 |
Why?
|
| Hippocampus | 7 | 1996 | 860 | 0.240 |
Why?
|
| Up-Regulation | 2 | 2021 | 910 | 0.240 |
Why?
|
| Neutrophils | 1 | 2007 | 362 | 0.230 |
Why?
|
| Candida tropicalis | 1 | 2024 | 17 | 0.220 |
Why?
|
| Candidiasis, Invasive | 1 | 2024 | 23 | 0.220 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2018 | 236 | 0.220 |
Why?
|
| Leukemia, Myeloid, Chronic-Phase | 1 | 2023 | 11 | 0.210 |
Why?
|
| Translocation, Genetic | 2 | 2018 | 363 | 0.210 |
Why?
|
| Benzeneacetamides | 3 | 2000 | 7 | 0.210 |
Why?
|
| Prognosis | 5 | 2024 | 5042 | 0.200 |
Why?
|
| Quinolines | 1 | 2023 | 115 | 0.200 |
Why?
|
| Antifungal Agents | 1 | 2024 | 306 | 0.190 |
Why?
|
| Gene Expression Regulation, Leukemic | 3 | 2018 | 68 | 0.180 |
Why?
|
| Cell Differentiation | 2 | 2018 | 2027 | 0.180 |
Why?
|
| Culture Media, Conditioned | 1 | 2021 | 85 | 0.180 |
Why?
|
| Hematologic Neoplasms | 1 | 2024 | 294 | 0.180 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2021 | 69 | 0.170 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 357 | 0.170 |
Why?
|
| Cryopreservation | 1 | 2021 | 73 | 0.170 |
Why?
|
| Interleukin-13 | 1 | 2021 | 98 | 0.170 |
Why?
|
| Humans | 27 | 2025 | 133257 | 0.170 |
Why?
|
| Male | 23 | 2025 | 65522 | 0.170 |
Why?
|
| Atovaquone | 1 | 2019 | 10 | 0.160 |
Why?
|
| Dentate Gyrus | 3 | 2000 | 55 | 0.160 |
Why?
|
| Sarcoma, Myeloid | 1 | 2019 | 11 | 0.160 |
Why?
|
| Pyrrolidines | 3 | 2000 | 41 | 0.160 |
Why?
|
| Interleukin-15 | 1 | 2020 | 96 | 0.160 |
Why?
|
| Proportional Hazards Models | 2 | 2021 | 1471 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2023 | 612 | 0.160 |
Why?
|
| Guinea Pigs | 7 | 2000 | 169 | 0.150 |
Why?
|
| Transcriptional Activation | 1 | 2021 | 500 | 0.150 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 126 | 0.150 |
Why?
|
| Dihydroergotamine | 1 | 2018 | 10 | 0.150 |
Why?
|
| Cytokines | 2 | 2022 | 1378 | 0.140 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2018 | 32 | 0.140 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 424 | 0.140 |
Why?
|
| Female | 15 | 2025 | 71436 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2018 | 82 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2018 | 88 | 0.140 |
Why?
|
| Long-Term Potentiation | 3 | 2000 | 163 | 0.140 |
Why?
|
| Phosphorylation | 2 | 2012 | 1706 | 0.140 |
Why?
|
| Mice, Inbred NOD | 4 | 2020 | 318 | 0.140 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 1463 | 0.140 |
Why?
|
| Dynorphins | 3 | 2000 | 10 | 0.140 |
Why?
|
| Vasoconstrictor Agents | 1 | 2018 | 147 | 0.130 |
Why?
|
| Young Adult | 4 | 2025 | 9923 | 0.130 |
Why?
|
| Flow Cytometry | 2 | 2024 | 814 | 0.130 |
Why?
|
| Animals | 22 | 2020 | 36203 | 0.130 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 232 | 0.130 |
Why?
|
| Interleukin-3 Receptor alpha Subunit | 1 | 2016 | 11 | 0.130 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 699 | 0.130 |
Why?
|
| Rhodium | 1 | 2015 | 4 | 0.120 |
Why?
|
| Histone Demethylases | 1 | 2016 | 43 | 0.120 |
Why?
|
| Ikaros Transcription Factor | 1 | 2015 | 32 | 0.120 |
Why?
|
| Syk Kinase | 1 | 2015 | 18 | 0.120 |
Why?
|
| Cell Proliferation | 5 | 2018 | 2559 | 0.120 |
Why?
|
| Cell Survival | 3 | 2019 | 884 | 0.120 |
Why?
|
| Glucocorticoids | 1 | 2018 | 401 | 0.120 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2021 | 1193 | 0.120 |
Why?
|
| Blotting, Western | 3 | 2016 | 1136 | 0.110 |
Why?
|
| Disease-Free Survival | 2 | 2017 | 965 | 0.110 |
Why?
|
| Synapses | 2 | 2000 | 470 | 0.110 |
Why?
|
| Transcription Factors | 1 | 2005 | 2720 | 0.110 |
Why?
|
| HL-60 Cells | 1 | 2014 | 35 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2019 | 1013 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 2 | 2018 | 1097 | 0.110 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2014 | 23 | 0.110 |
Why?
|
| Histones | 2 | 2016 | 572 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 1915 | 0.110 |
Why?
|
| Synaptic Transmission | 2 | 1997 | 365 | 0.110 |
Why?
|
| Neural Inhibition | 2 | 1994 | 110 | 0.100 |
Why?
|
| Endorphins | 2 | 1994 | 6 | 0.100 |
Why?
|
| Stromal Cells | 1 | 2015 | 314 | 0.100 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2020 | 899 | 0.100 |
Why?
|
| Filgrastim | 1 | 2012 | 12 | 0.100 |
Why?
|
| Leukemia | 1 | 2016 | 374 | 0.100 |
Why?
|
| Mice | 10 | 2020 | 18937 | 0.100 |
Why?
|
| Intestinal Perforation | 1 | 2013 | 55 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 1325 | 0.100 |
Why?
|
| Cell Separation | 1 | 2012 | 231 | 0.090 |
Why?
|
| Mice, SCID | 3 | 2018 | 614 | 0.090 |
Why?
|
| Cell Cycle | 1 | 2014 | 619 | 0.090 |
Why?
|
| Radiation Dosage | 1 | 2012 | 146 | 0.090 |
Why?
|
| Burkitt Lymphoma | 1 | 2013 | 141 | 0.090 |
Why?
|
| DNA Damage | 1 | 2014 | 517 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 584 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 788 | 0.090 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 312 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 2125 | 0.080 |
Why?
|
| Nerve Fibers | 2 | 2000 | 76 | 0.080 |
Why?
|
| Hodgkin Disease | 1 | 2012 | 295 | 0.080 |
Why?
|
| Ligands | 1 | 2011 | 571 | 0.080 |
Why?
|
| Protein Isoforms | 2 | 2007 | 432 | 0.080 |
Why?
|
| Axons | 3 | 2000 | 397 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 1433 | 0.080 |
Why?
|
| Adult | 4 | 2025 | 31646 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2012 | 1584 | 0.080 |
Why?
|
| Neurons | 3 | 2000 | 2050 | 0.070 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 818 | 0.070 |
Why?
|
| Dendrites | 2 | 2000 | 204 | 0.070 |
Why?
|
| Pilocarpine | 1 | 1997 | 13 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2020 | 111 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 1770 | 0.070 |
Why?
|
| Neoplasms, Experimental | 2 | 2020 | 223 | 0.070 |
Why?
|
| Elapid Venoms | 1 | 1996 | 10 | 0.060 |
Why?
|
| Structure-Activity Relationship | 2 | 2020 | 607 | 0.060 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 1997 | 91 | 0.060 |
Why?
|
| Membrane Transport Proteins | 1 | 2007 | 188 | 0.060 |
Why?
|
| Presynaptic Terminals | 1 | 1996 | 83 | 0.060 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 4759 | 0.060 |
Why?
|
| Potassium Channels | 1 | 1996 | 166 | 0.060 |
Why?
|
| Cell Line | 2 | 2007 | 2855 | 0.060 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2005 | 19 | 0.060 |
Why?
|
| Adenylyl Cyclases | 1 | 1995 | 81 | 0.060 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2007 | 314 | 0.060 |
Why?
|
| Drug Resistance, Fungal | 1 | 2024 | 30 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2007 | 689 | 0.060 |
Why?
|
| Risk Factors | 2 | 2024 | 10956 | 0.060 |
Why?
|
| Milk Proteins | 1 | 2005 | 92 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2011 | 2876 | 0.060 |
Why?
|
| Calcium Channels | 1 | 1995 | 165 | 0.060 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 102 | 0.060 |
Why?
|
| Karyotyping | 2 | 2015 | 321 | 0.050 |
Why?
|
| Granulocytes | 1 | 1994 | 71 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 2191 | 0.050 |
Why?
|
| Aniline Compounds | 1 | 2023 | 20 | 0.050 |
Why?
|
| Drug Design | 1 | 2005 | 168 | 0.050 |
Why?
|
| Neurotransmitter Agents | 1 | 1994 | 150 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2025 | 366 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 1994 | 209 | 0.050 |
Why?
|
| Nitriles | 1 | 2023 | 155 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2015 | 781 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2005 | 477 | 0.050 |
Why?
|
| Analgesics | 3 | 2000 | 131 | 0.050 |
Why?
|
| Norepinephrine | 1 | 1992 | 174 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2024 | 834 | 0.040 |
Why?
|
| Learning | 1 | 1995 | 375 | 0.040 |
Why?
|
| In Vitro Techniques | 3 | 2000 | 960 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 1991 | 123 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2005 | 835 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 1991 | 85 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2019 | 35 | 0.040 |
Why?
|
| Computational Biology | 1 | 2024 | 887 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 464 | 0.040 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2020 | 175 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2005 | 1341 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 1714 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2024 | 8627 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 407 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2018 | 128 | 0.030 |
Why?
|
| Brain | 2 | 1995 | 3224 | 0.030 |
Why?
|
| Incidence | 1 | 2024 | 3389 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2020 | 1147 | 0.030 |
Why?
|
| Kinetics | 3 | 2007 | 1323 | 0.030 |
Why?
|
| Antigens, CD20 | 1 | 2016 | 40 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2018 | 281 | 0.030 |
Why?
|
| U937 Cells | 1 | 2016 | 25 | 0.030 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2016 | 11 | 0.030 |
Why?
|
| Genes, Transgenic, Suicide | 1 | 2016 | 48 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2024 | 17555 | 0.030 |
Why?
|
| Complement System Proteins | 1 | 2016 | 58 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 2145 | 0.030 |
Why?
|
| CD3 Complex | 1 | 2016 | 91 | 0.030 |
Why?
|
| Retroviridae | 1 | 2016 | 198 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1852 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2016 | 238 | 0.030 |
Why?
|
| Methylation | 1 | 2016 | 232 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2016 | 233 | 0.030 |
Why?
|
| Catalysis | 1 | 2015 | 141 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2016 | 271 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2016 | 297 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 351 | 0.030 |
Why?
|
| Lysine | 1 | 2016 | 207 | 0.030 |
Why?
|
| Rituximab | 1 | 2016 | 165 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2016 | 319 | 0.030 |
Why?
|
| Evoked Potentials | 2 | 1996 | 124 | 0.030 |
Why?
|
| RNA, Long Noncoding | 1 | 2018 | 248 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 1996 | 349 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 1991 | 1049 | 0.030 |
Why?
|
| Leukocytosis | 1 | 2014 | 48 | 0.030 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2014 | 67 | 0.030 |
Why?
|
| Antibody Specificity | 2 | 1996 | 198 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2015 | 541 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2014 | 149 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 767 | 0.020 |
Why?
|
| Binding Sites | 1 | 2015 | 1378 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2016 | 965 | 0.020 |
Why?
|
| DNA | 1 | 2018 | 1675 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1340 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 1067 | 0.020 |
Why?
|
| Peptides | 2 | 1996 | 863 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2014 | 373 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 558 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 543 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2019 | 3979 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 1996 | 1730 | 0.020 |
Why?
|
| Dipeptidases | 1 | 1990 | 15 | 0.020 |
Why?
|
| Middle Aged | 2 | 2025 | 28950 | 0.020 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 2000 | 14 | 0.020 |
Why?
|
| Rats | 3 | 1997 | 3851 | 0.020 |
Why?
|
| Receptors, GABA-A | 1 | 2000 | 59 | 0.020 |
Why?
|
| Calcium | 2 | 1995 | 1104 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1965 | 0.020 |
Why?
|
| Mutation | 2 | 2015 | 6342 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2023 | 13103 | 0.020 |
Why?
|
| Luciferases | 1 | 2007 | 136 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1991 | 233 | 0.020 |
Why?
|
| Aged | 1 | 2025 | 21475 | 0.020 |
Why?
|
| Tetraethylammonium Compounds | 1 | 1996 | 6 | 0.020 |
Why?
|
| Bee Venoms | 1 | 1996 | 7 | 0.020 |
Why?
|
| Nerve Endings | 1 | 1996 | 8 | 0.020 |
Why?
|
| Tetraethylammonium | 1 | 1996 | 11 | 0.020 |
Why?
|
| Barium | 1 | 1996 | 18 | 0.020 |
Why?
|
| 4-Aminopyridine | 1 | 1996 | 35 | 0.020 |
Why?
|
| Glyburide | 1 | 1996 | 24 | 0.020 |
Why?
|
| Shaker Superfamily of Potassium Channels | 1 | 1996 | 31 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 1996 | 129 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 402 | 0.020 |
Why?
|
| Neurotoxins | 1 | 1996 | 58 | 0.020 |
Why?
|
| omega-Conotoxin GVIA | 1 | 1995 | 7 | 0.010 |
Why?
|
| Isradipine | 1 | 1995 | 6 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 787 | 0.010 |
Why?
|
| Nifedipine | 1 | 1995 | 22 | 0.010 |
Why?
|
| Naltrexone | 1 | 1995 | 70 | 0.010 |
Why?
|
| Genomic Library | 1 | 1995 | 42 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 1995 | 116 | 0.010 |
Why?
|
| Mice, Neurologic Mutants | 1 | 1995 | 74 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1995 | 191 | 0.010 |
Why?
|
| Afferent Pathways | 1 | 1994 | 16 | 0.010 |
Why?
|
| Autoradiography | 1 | 1994 | 73 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1994 | 79 | 0.010 |
Why?
|
| Dominance, Cerebral | 1 | 1994 | 55 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1996 | 834 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1997 | 1303 | 0.010 |
Why?
|
| Oocytes | 1 | 1996 | 301 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1995 | 249 | 0.010 |
Why?
|
| Brain Stem | 1 | 1995 | 119 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1994 | 400 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2007 | 890 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1992 | 27 | 0.010 |
Why?
|
| Naloxone | 1 | 1992 | 50 | 0.010 |
Why?
|
| Propranolol | 1 | 1992 | 121 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1992 | 288 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 1995 | 481 | 0.010 |
Why?
|
| Cerebellum | 1 | 1995 | 467 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1991 | 252 | 0.010 |
Why?
|
| Dipeptides | 1 | 1991 | 64 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1991 | 193 | 0.010 |
Why?
|
| Spinal Cord | 1 | 1991 | 275 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1995 | 3131 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1991 | 1083 | 0.010 |
Why?
|
| Time Factors | 1 | 1994 | 6545 | 0.010 |
Why?
|
| Glutamate Carboxypeptidase II | 1 | 1990 | 6 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1990 | 71 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1990 | 67 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1990 | 96 | 0.010 |
Why?
|
| Synaptosomes | 1 | 1990 | 31 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 1990 | 67 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1990 | 65 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 304 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1990 | 384 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1990 | 439 | 0.010 |
Why?
|